CervoMed (CRVO) Long-Term Debt Issuances (2010 - 2014)
CervoMed (CRVO) posted Long-Term Debt Issuances of $400000.0 for Q1 2014, down 38.46% sequentially from $650000.0 in Q4 2013, and up 300.0% YoY from $100000.0 in Q1 2013.
CervoMed (CRVO) Long-Term Debt Issuances (2010 - 2014) Analysis & Trends
CervoMed has reported Long-Term Debt Issuances for 5 years, with the latest figure at $400000.0 in Q1 2014.
- Quarterly Long-Term Debt Issuances rose 300.0% year-over-year to $400000.0 in Q1 2014, while the trailing twelve-month figure through Dec 2014 was $400000.0 (down 42.86% YoY) and the FY2016 annual result came in at $1.9 million, down 21.72% from the prior year.
- Long-Term Debt Issuances fell to $400000.0 in Q1 2014 per CRVO's latest filing, from $650000.0 in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $2.8 million in Q4 2012 and troughed at -$1.8 million in Q1 2012.
- A 5-year average of $101005.6 and a median of $55001.0 in 2011 frame the typical range for Long-Term Debt Issuances.
- The widest YoY moves for Long-Term Debt Issuances: up 1435.15% in 2012, down 1324.19% in 2012.
- Over 5 years, Long-Term Debt Issuances stood at -$196937.0 in 2010, then jumped by 194.07% to $185267.0 in 2011, then surged by 1435.15% to $2.8 million in 2012, then tumbled by 77.15% to $650000.0 in 2013, then slumped by 38.46% to $400000.0 in 2014.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $400000.0, $650000.0, and -$150000.0 for Q1 2014, Q4 2013, and Q3 2013 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 1.14 Mn |
| Sep 30, 2014 | 1.14 Mn |
| Mar 31, 2014 | 400,000.00 |
| Mar 31, 2014 | 400,000.00 |
| Dec 31, 2013 | 650,000.00 |
| Dec 31, 2013 | 650,000.00 |
| Sep 30, 2013 | -150,000.00 |
| Sep 30, 2013 | -150,000.00 |
| Jun 30, 2013 | 400,000.00 |
| Jun 30, 2013 | 400,000.00 |
| Mar 31, 2013 | -200,000.00 |
| Mar 31, 2013 | -200,000.00 |
| Dec 31, 2012 | 2.84 Mn |
| Dec 31, 2012 | 2.84 Mn |
| Sep 30, 2012 | -673,317.00 |
| Sep 30, 2012 | -673,317.00 |
| Jun 30, 2012 | -366,027.00 |
| Jun 30, 2012 | -366,027.00 |
| Mar 31, 2012 | -1.83 Mn |
| Mar 31, 2012 | -1.83 Mn |